Business Context and Reporting Period
This Form 6-K filing by Blue Gold Limited covers the month of January 2026, specifically reporting on corporate actions taken on January 23, 2026. The company, a Cayman Islands-based foreign private issuer, entered into an Omnibus Amendment to existing debt and warrant agreements and issued new senior convertible debt and warrants to an investor.
Key Financial Metrics and Capital Structure
The filing details specific debt instruments and equity-linked securities but does not provide consolidated financial statements, revenue, profit, or cash flow data.
- Existing Debt: Two senior convertible notes totaling $5,434,783 ($3,804,348 First Note and $1,630,435 Second Note).
- New Debt: A new senior convertible note ("January Note") issued with a principal amount of $1,630,435, maturing on January 23, 2027.
- Warrants: Existing warrants covering 215,299 shares and a new warrant ("January Warrant") covering 64,590 shares.
- Conversion Terms: Conversion price for existing notes fixed at $3.00 through February 15, 2026, then subject to a variable formula with a $0.50 floor.
- Warrant Exercise Price: Amended to $0.01 per share for existing warrants; new warrant also set at $0.01 per share.
Material Changes Versus Prior Period
The filing outlines significant amendments to the terms of the company's debt and equity instruments compared to the prior agreements:
- Sale Restrictions: New covenants limit the investor's ability to sell conversion or warrant shares to the greater of 10% of daily trading volume or $10,000 (through Feb 15, 2026) and $40,000 thereafter.
- Payment Terms: Installment payment obligations for cash were eliminated for dates after January 1, 2026, except for the maturity date.
- Default Provisions: Clarified that failure to pay principal or interest constitutes an event of default, with a ten-trading-day cure period applicable solely to unpaid interest and late charges.
- Redemption Mechanics: Added a five-trading-day election period for the investor to convert notes following a company optional redemption notice.
Outlook, Risks, and Contingencies
Management commentary is limited to the description of the transaction terms. Key risks and contingencies identified include:
- Dilution Risk: The investor is restricted from beneficially owning more than 4.99% (or 9.99% at their option) of outstanding shares, which may limit conversion or exercise.
- Covenants: The new note includes negative covenants prohibiting additional indebtedness, liens, asset transfers, and changes in the nature of the business.
- Liquidity and Registration: The new securities were issued under Section 4(a)(2) and Rule 506(b) exemptions and cannot be resold without registration or an exemption.
- Default Risk: Standard events of default include bankruptcy, insolvency, and unsatisfied judgments.
Investor Verification Checklist
- Verify the total outstanding principal debt load, now including the new $1.63 million January Note.
- Confirm the impact of the $0.01 warrant exercise price on potential future dilution.
- Review the specific "events of default" clauses to understand the company's current compliance status regarding interest and principal payments.
- Assess the liquidity impact of the new sale restrictions on the investor's ability to exit positions.
- Check for any subsequent filings regarding the company's ability to meet the maturity date of January 23, 2027.